---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-001983"
form_type: "8-K"
ticker: null
cik: "0001411906"
company_name: "Ampio Pharmaceuticals, Inc."
filed_at: "2024-02-28T23:59:59+00:00"
generated_at: "2026-06-05T08:32:43.309866+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ampio terminates at-the-market equity offering agreement with H.C. Wainwright

## Summary
- Termination notice issued Feb 26, 2024; effective March 6, 2024.
- Filed post-effective amendment to withdraw all unsold shares from registration.
- ATM program originally established September 18, 2023.
- No securities sold under the program since termination.

## SEC filing metadata
- accession: 0001558370-24-001983
- form_type: 8-K
- cik: 0001411906
- company_name: Ampio Pharmaceuticals, Inc.
- filed_at: 2024-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411906/000155837024001983/0001558370-24-001983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411906/000155837024001983/ampe-20240226x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-001983
- JSON: https://secwatch.observer/filing/0001558370-24-001983.json
- Plain text: https://secwatch.observer/filing/0001558370-24-001983.txt

## Key facts
- Material Agreements
  Ampio Pharmaceuticals, Inc. terminated ATM Agreement with H.C. Wainwright & Co., LLC (effective 2024-02-26).
  - Action: termination
  - Agreement: atm program
  - Counterparty: H.C. Wainwright & Co., LLC
  - Effective: 2024-02-26
  source text: On February 26, 2024, Ampio Pharmaceuticals, Inc. (the “Company”) provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C. Wainwright & Co., LLC (the “ATM Agreement”), establishing an at-the-market equity distribution program for the offer and sale from time to time shares of the Company’s common stock, par value $0.0001.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411906/000155837024001983/0001558370-24-001983-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.